| | | | | | | | Welcome to Editors' (re)View, a feature where the Pharma Manufacturing editors handpick notable pharma world happenings that deserve some extra consideration. See what you may have missed this week in pharma. |
|
|
|
| |
| | |
|
|
| | | | | Beqvez, priced at $3.5 million in the U.S., is tied with CSL's hemophilia therapy as the second most expensive drug in the world. |
|
|
| The new 'Advanced Research Center' is part of a $1.6 billion investment initiative at the company's Darmstadt site. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome the challenges to de-risk & optimize the path to manufacturing success. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|